Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Experimental Nephrology
Published in: Clinical and Experimental Nephrology 4/2009

01-08-2009 | Case Report

Acute pancreatitis with CMV papillitis and cholangiopathy in a renal transplant recipient

Authors: Bagchi Soumita Kamalkumar, Sanjay Kumar Agarwal, Pramod Garg, Amit Dinda, Suresh Chand Tiwari

Published in: Clinical and Experimental Nephrology | Issue 4/2009

Login to get access

Abstract

Acute pancreatitis with cholangiopathy is an uncommon complication in renal transplant patients. Further, a combination of pancreatitis and cholangiopathy due to CMV disease in renal allograft recipient is further uncommon. We report a renal transplant recipient who developed acute pancreatitis and cholangiopathy with CMV papillitis of the Ampulla of Vater.
Literature
1.
2.
Fernandez-Cruz L, Targarona EM, Cugat E, Alcaraz A, Oppenheimer F. Acute pancreatitis after renal transplantation. Br J Surg. 1989;76:1132–5.CrossRefPubMed
3.
Sinha S, Jha R, Lakhtakia S, Narayan G. Acute pancreatitis following renal transplantation—role of viral infections. Clin Transplant. 2003;17:32–6.CrossRefPubMed
4.
Soderdahl G, Tyden G, Groth CG. Incidence of gastrointestinal complications following renal transplantation in the cyclosporin era. Transplant Proc. 1994;26:1771–2.PubMed
5.
Harold H, Goral S. Gastrointestinal complications of transplantation immunosuppression. JASN. 2002;13:277–87.
6.
Lorber MI, Van Buren CT, Flechner SM, Williams C, Kahan BDI. Hepatobiliary and pancreatic complications of cyclosporine therapy in 466 renal transplant recipients. Transplantation. 1987;43(1):35–40.CrossRefPubMed
7.
Stone B, Warty V, Dindzans V, Van Thiel D (1988). The mechanism of cyclosporine induced cholestasis in the rat. Transplant Proc 20(Suppl 3):841–4.PubMed
8.
Cello JP. Acquired immunodeficiency syndrome cholangiopathy; spectrum of disease. Am J Med. 1989;86(5):539–46.CrossRefPubMed
9.
Cheung AN, Ng IO. Cytomegalovirus infection of the gastrointestinal tract in non-AIDS patients. Am J Gastroenterol. 1993;88:1882–6.PubMed
Metadata
Title
Acute pancreatitis with CMV papillitis and cholangiopathy in a renal transplant recipient
Authors
Bagchi Soumita Kamalkumar
Sanjay Kumar Agarwal
Pramod Garg
Amit Dinda
Suresh Chand Tiwari
Publication date
01-08-2009
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 4/2009
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-008-0123-9

Other articles of this Issue 4/2009

Clinical and Experimental Nephrology 4/2009 Go to the issue

Original Article

Infective endocarditis in hemodialysis patients: clinical features, echocardiographic data and outcome

Review Article

Nocturnal hemodialysis

Original Article

Nitrosative stress, protein tyrosine nitration, PARP activation and NAD depletion in the kidneys of rats after single dose of cyclophosphamide

Original Article

Ultrasonography as a predictor of overt bleeding after renal biopsy

Case Report

Nephrotic-range proteinuria in a patient with a renal allograft treated with sorafenib for metastatic renal-cell carcinoma

Guidelines

Aliskiren as an antiproteinuric add-on therapy in primary membranous nephropathy
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits